Researchers flag new cancer therapy that guards p53

admin — Tue, 06 May 2008 06:59:59 -0400

Scientists in Scotland say that they have identified a chemical group that can protect the p53 gene, a guardian against cancer tumors which is damaged or turned off in most cancer cases. They believe Read more...

Fat cell research points to new approach on obesity

admin — Tue, 06 May 2008 06:59:59 -0400

Swedish researchers have concluded that the number of fat cells present in the body is a constant, remaining unchanged regardless of how much a person weighs or gains. Every year about 10 percent of Read more...

Scientists forecasts use of stem cells to grow parts

admin — Tue, 06 May 2008 06:59:59 -0400

UK cell biologist Robert Edwards says he can see a time in the not-too-distant future when humans will be able to grow new body parts through the use of stem cell technology. And the doctor, Read more...

ALSO NOTED: StemCyte to open NJ facility; Cornell researchers win million-dollar grant;

admin — Tue, 06 May 2008 06:59:58 -0400

Stem Cell Research California's StemCyte will open a facility in New Jersey and hire 12 people to do stem cell research work. The company was drawn to the state with $589,000 in state grants. Read more...

Chance discovery links ACE inhibitors to weight loss

admin — Tue, 29 Apr 2008 06:59:59 -0400

Australian scientists say that targeting angiotensin converting enzyme (ACE) can be an effective way to spur weight loss and prevent diabetes. And the research demonstrates that ACE-inhibitors could Read more...

Consortium uses 'virtual patients' to find drugs

admin — Tue, 29 Apr 2008 06:59:59 -0400

Pfizer is providing $14.4 million to fund a research consortium involving four universities and Entelos, a company that does computer modeling for drug research work, in a drive to create a new class Read more...

Gene therapy helps improve sight of the blind

admin — Tue, 29 Apr 2008 06:59:59 -0400

Two new human trials of a gene therapy for inherited blindness have demonstrated that injecting replacement genes under the retinas of the blind can spur at least partial sight in some volunteers. In Read more...

Counterpoint: An argument for industry-backed research

admin — Tue, 29 Apr 2008 06:59:59 -0400

Management consultant Dr. David A. Shaywitz has joined with Dr. Dennis A. Ausiello, the physician-in-chief of Massachusetts General Hospital and a director at Pfizer, to deliver a rebuttal to a small Read more...